CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metabolix, Inc. (NASDAQ: MBLX) today announced that Telles™, the joint venture between Metabolix Inc. and Archer Daniels Midland Company that produces Mirel™ bioplastics, has made three new hires to support the technical development of Mirel. Joining Telles are Joseph Huang, Product Development Engineer, David Scarlett, Laboratory Manager, and Thomas J. Pitzi, Application Development Engineer.
